1. Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene by Xiaoou Zhou, Antonio Di Stasi, Siok-Keen Tey, Robert A. Krance, Caridad Martinez, Kathryn S. Leung, April G. Durett, Meng-Fen Wu, Hao Liu, Ann M. Leen, Barbara Savoldo, Yu-Feng Lin, Bambi J. Grilley, Adrian P. Gee, David M. Spencer, Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner, and Gianpietro Dotti Blood Volume 123(25):3895-3905 June 19, 2014 ©2014 by American Society of Hematology

2. Overall immune reconstitution in patients infused with iC9-T cells. Xiaoou Zhou et al. Blood 2014;123:3895-3905 ©2014 by American Society of Hematology

3. Administration of AP1903 does not adversely affect T-cell immune recovery. Xiaoou Zhou et al. Blood 2014;123:3895-3905 ©2014 by American Society of Hematology

4. Antiviral immune reconstitution after iC9-T-cell infusion. Xiaoou Zhou et al. Blood 2014;123:3895-3905 ©2014 by American Society of Hematology

5. Recovery of antiviral immune responses after iC9-T-cell infusion and administration of AP1903. Xiaoou Zhou et al. Blood 2014;123:3895-3905 ©2014 by American Society of Hematology

6. Anti-Aspergillus fumigatus immune-response after iC9-T-cell infusion and administration of AP1903. Xiaoou Zhou et al. Blood 2014;123:3895-3905 ©2014 by American Society of Hematology